Cornell Tech researchers unveiled a robot that helps emergency room teams locate life-saving supplies faster, revealing how design can shape collaboration under pressure.
Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center provide fresh insights about how cancers evolve when they metastasize – insights that could aid in developing strategies to improve the effectiveness of treatment.
A clinical trial in patients with advanced breast cancer has found the use of liquid biopsy blood tests for early detection of a treatment-resistant mutation, followed by a new type of treatment, substantially extends the period of tumor control.
The Varian Edge linear accelerator provides state-of-the art, non-invasive radiotherapy treatments. The closest comparable facilities are in New York City, and while approximately 40% of veterinary schools have radiation oncology programs, few have access to such technology. Cornell’s Varian Edge replaces machinery previously installed in 2000.
Imprint, an organization founded at Cornell Tech that is dedicated to decoding the body’s immune memory and uncovering the causes of chronic diseases, announced that it has raised over $15 million in funding.
A team of Cornell researchers is exploring how workplace tracking apps can be used not to surveil workers, but to help them build solidarity and improve their working conditions.